Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis C beta-interferon-induced severe hypertriglyceridaemia with apolipoprotein E phenotype E3/2.

Y Homma1, K Kawazoe, T Ito

  • 1Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.

International Journal of Clinical Practice
|July 27, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between the combination of polyunsaturated fatty acids intake and psychological distress during pregnancy: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.

Prostaglandins, leukotrienes, and essential fatty acids·2022
Same author

Characterization and biological evaluation of the introduction of PLGA into biosilicate<sup>®</sup>.

Journal of biomedical materials research. Part B, Applied biomaterials·2016
Same author

[Surgical treatment of an endobronchial inflammatory pseudotumor].

Kyobu geka. The Japanese journal of thoracic surgery·2008
Same author

Mesenchyme with fgf-10 expression is responsible for regenerative capacity in Xenopus limb buds.

Developmental biology·2000
Same author

Substrate specificity of human methylpurine DNA N-glycosylase.

Biochemistry·2000
Same author

Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine.

The Journal of biological chemistry·2000

Beta-interferon treatment increased triglyceride levels in a hepatitis C patient by reducing lipoprotein lipase (LPL) activity. Normal IDL levels were maintained due to high LDL-receptor activity, despite the apo E3/2 phenotype.

Area of Science:

  • Biochemistry
  • Hepatology
  • Pharmacology

Background:

  • Investigated mechanisms of hypertriglyceridaemia and lipoprotein subfraction changes during beta-interferon treatment.
  • Focused on a hepatitis C patient with apolipoprotein E (apo E) phenotype E3/2, known for impaired clearance of triglyceride-rich lipoproteins.

Observation:

  • Beta-interferon treatment elevated plasma triglyceride (TG) levels significantly.
  • Lipoprotein lipase (LPL) mass and activity were reduced by half, while hepatic triglyceride lipase (HTGL) activity remained normal.
  • Despite the apo E3/2 phenotype, plasma levels of intermediate-density lipoprotein (IDL) were normal due to high LDL-receptor activity.

Findings:

  • Beta-interferon induced hypertriglyceridaemia by suppressing LPL activity.
  • Normal IDL levels were maintained through enhanced LDL-receptor-mediated clearance, compensating for impaired remnant removal associated with the apo E3/2 phenotype.

Related Experiment Videos

  • Lipoprotein subfraction distribution normalized upon discontinuation of interferon treatment.

    • Implications:

    • Highlights the complex interplay between interferon therapy, LPL activity, LDL-receptor function, and lipid metabolism in patients with specific apo E phenotypes.
    • Suggests that interferon-induced hypertriglyceridaemia can be managed through understanding and potentially modulating LDL-receptor activity.
    • Provides insights into lipoprotein metabolism in hepatitis C patients undergoing antiviral therapy.